A company of theRHÖN-KLINIKUM AG
Deutsch
A A A
DE
A A A
Deutsch
Philipps Universität Marburg Philipps Universität Marburg Fachbereich 20 – Medizin
Justus-Liebig-Universität Gießen Justus-Liebig-Universität Gießen Fachbereich 11 – Medizin
Bereichsnavigation

Previous
RHÖN-KLINIKUM AG | 08/05/2009

RHÖN-KLINIKUM AG determines volume of capital increase

  • Shareholders accept subscription offer, investing in growth
  • Vote of confidence in business model
  • Issuance of 34,552,000 no-par value shares
  • Gross issue proceeds of approx. € 460 million

Today the management board of RHÖN-KLINIKUM AG determined, with the supervisory board’s approval, the volume of the capital increase from authorised capital resolved on 19 July 2009. The company’s share capital is to be increased from €259,200,000 by €86,380,000 to €345,580,000 by way of an issuance of 34,552,000 no-par value shares, each with a pro-rata interest in the company’s registered share capital of €2.50. The application for registration of the capital increase in the commercial register will be filed on 6 August 2009. 99.9% of the new shares were subscribed for by holders of subscription rights. The small number of remaining shares was sold today by the Joint Bookrunners/Joint Lead Managers COMMERZBANK Aktiengesellschaft and Morgan Stanley Bank AG as part of a private placement. The gross issue proceeds amount to approx. € 460 million.

“We are pleased that the offer to invest in our business model was very well received by the shareholders. We view these investment as the foundation of our future growth”, stated Wolfgang Pföhler, chairman of the management board of RHÖN-KLINIKUM AG. CFO Dr. Erik Hamann was delighted that a percentage of 99.9% of subscription rights had been exercised: “This shows the tremendous trust that shareholders place in our business strategy.”

In RHÖN-KLINIKUM AG’s view, the capital increase was carried out from a position of strength. The company believes that its successful capital increase positions it to present itself to public sector entities as a prospective business partner having scope for action in the privatisation wave expected to emerge from 2010 onwards. The ability to innovate and invest in the medical field are core elements of the long-term corporate strategy of RHÖN-KLINIKUM AG.

“As an experienced and reliable healthcare provider, we offer municipalities and the federal states an efficient and attractive means to fulfil their care mandate. Our objective is to provide a broad spectrum of high-quality and affordable healthcare to everyone”, emphasises Wolfgang Pföhler.